3617-1625 Screening compound: N-(1,3-benzothiazol-2-yl)-3-bromo-4-methoxybenzamide

3617-1625 Screening compound: N-(1,3-benzothiazol-2-yl)-3-bromo-4-methoxybenzamide
3617-1625 Screening compound: N-(1,3-benzothiazol-2-yl)-3-bromo-4-methoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 3617-1625
N-(1,3-benzothiazol-2-yl)-3-bromo-4-methoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3617-1625

Molecular Formula

C15H11BrN2O2S (C15 H11 BrN2 O2 S)

Compound Name

N-(1,3-benzothiazol-2-yl)-3-bromo-4-methoxybenzamide

IUPAC name

N-(13-benzothiazol-2-yl)-3-bromo-4-methoxybenzamide

SMILES

COc(ccc(C(Nc1nc(cccc2)c2s1)=O)c1)c1Br

InChI

InChI=1S/C15H11BrN2O2S/c1-20-12-7-6-9(8-10(12)16)14(19)18-15-17-11-4-2-3-5-13(11)21-15/h2-8H,1H3,(H,17,18,19)

InChI Key

VRCKUSNKEQRHRQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02219032

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

363.23

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.528

Distribution Coefficient, logD

4.522

Water Solubility, LogSw

-4.44

Polar Surface Area

40.721

Acid Dissociation Constant (pKa)

9.23

Base Dissociation Constant (pKb)

-0.92

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

6.70

3617-1625 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Aging Library (44940 compounds)

Anti-infective Library (19449 compounds)

Antimitotic Tubulin Library (17355 compounds)

Antiviral Library (67538 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 3617-1625 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3617-1625?
Check Price and Availability of 3617-1625, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3617-1625 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3617-1625
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3617-1625
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3617-1625 available by request